Skip to content
10-K

Annual Report

Akcea Therapeutics, Inc.

0001564590-20-008119

← back to feed
Filed
Mar 2, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Feb 20, 2020 101.07M sh
Capex FY 2019 · Dec 31, 2019 $1.6M
Capex FY 2019 · Dec 31, 2018 $1.12M
Capex FY 2019 · Dec 31, 2017 $9K
Operating Cash Flow FY 2019 · Dec 31, 2019 $223.83M
Operating Cash Flow FY 2019 · Dec 31, 2018 −$202.89M
Operating Cash Flow FY 2019 · Dec 31, 2017 −$36.19M
Cash And Equivalents FY 2019 · Dec 31, 2019 $306.87M
Cash And Equivalents FY 2019 · Dec 31, 2018 $86.45M
Cash And Equivalents FY 2019 · Dec 31, 2017 $58.37M
Stockholders Equity FY 2019 · Dec 31, 2019 $543M
Stockholders Equity FY 2019 · Dec 31, 2018 $276.72M
Current Liabilities FY 2019 · Dec 31, 2019 $42M
Current Liabilities FY 2019 · Dec 31, 2018 $80.66M
Total Liabilities FY 2019 · Dec 31, 2019 $56.25M
Total Liabilities FY 2019 · Dec 31, 2018 $88.54M
Current Assets FY 2019 · Dec 31, 2019 $496.91M
Current Assets FY 2019 · Dec 31, 2018 $267.24M
Total Assets FY 2019 · Dec 31, 2019 $599.25M
Total Assets FY 2019 · Dec 31, 2018 $365.26M
Sga Expense FY 2019 · Dec 31, 2019 $51.43M
Sga Expense FY 2019 · Dec 31, 2019 $181.68M
Sga Expense FY 2019 · Sep 30, 2019 $34.91M
Sga Expense FY 2019 · Jun 30, 2019 $50.74M
Sga Expense FY 2019 · Mar 31, 2019 $44.6M
Sga Expense FY 2019 · Dec 31, 2018 $45.93M
Sga Expense FY 2019 · Dec 31, 2018 $153.61M
Sga Expense FY 2019 · Sep 30, 2018 $45.92M
Sga Expense FY 2019 · Jun 30, 2018 $42.29M
Sga Expense FY 2019 · Mar 31, 2018 $19.47M
Sga Expense FY 2019 · Dec 31, 2017 $36.98M
Net Income FY 2019 · Dec 31, 2019 $82.41M
Net Income FY 2019 · Dec 31, 2019 $40.77M
Net Income FY 2019 · Sep 30, 2019 −$31.5M
Net Income FY 2019 · Jun 30, 2019 −$37.32M
Net Income FY 2019 · Mar 31, 2019 $27.19M
Net Income FY 2019 · Dec 31, 2018 −$70.56M
Net Income FY 2019 · Dec 31, 2018 −$225.82M
Net Income FY 2019 · Sep 30, 2018 −$63.59M
Net Income FY 2019 · Jun 30, 2018 −$62.05M
Net Income FY 2019 · Mar 31, 2018 −$29.63M
Net Income restated FY 2019 · Dec 31, 2017 −$121.56M
Operating Income FY 2019 · Dec 31, 2019 $83.16M
Operating Income FY 2019 · Dec 31, 2019 $38.07M
Operating Income FY 2019 · Sep 30, 2019 −$32.59M
Operating Income FY 2019 · Jun 30, 2019 −$38.71M
Operating Income FY 2019 · Mar 31, 2019 $26.21M
Operating Income FY 2019 · Dec 31, 2018 −$72.06M
Operating Income FY 2019 · Dec 31, 2018 −$230.82M
Operating Income FY 2019 · Sep 30, 2018 −$65.01M
Operating Income FY 2019 · Jun 30, 2018 −$63.42M
Operating Income FY 2019 · Mar 31, 2018 −$30.33M
Operating Income restated FY 2019 · Dec 31, 2017 −$120.47M
Revenue FY 2019 · Dec 31, 2019 $277.48M
Revenue FY 2019 · Dec 31, 2019 $488.54M
Revenue FY 2019 · Sep 30, 2019 $20.62M
Revenue FY 2019 · Jun 30, 2019 $26.62M
Revenue FY 2019 · Mar 31, 2019 $163.82M
Revenue FY 2019 · Dec 31, 2018 $10.2M
Revenue FY 2019 · Dec 31, 2018 $64.87M
Revenue FY 2019 · Sep 30, 2018 $19.24M
Revenue FY 2019 · Jun 30, 2018 $18.32M
Revenue FY 2019 · Mar 31, 2018 $17.11M
Revenue FY 2019 · Dec 31, 2017 $43.4M